Literature DB >> 1343838

Cerebral carbohydrate and energy metabolism in perinatal hypoxic-ischemic brain damage.

R C Vannucci1.   

Abstract

Cerebral hypoxia-ischemia remains a major cause of acute perinatal brain injury. Research in experimental animals over the past decade has greatly expanded our knowledge of those oxidative events which occur during a hypoxic-ischemic insult to the brain, as well as those metabolic alterations which evolve during the recovery period following resuscitation. The available evidence suggests that hypoxia alone does not lead to brain damage, but rather a combination of hypoxia-ischemia or isolated cerebral ischemia is a necessary prerequisite for tissue injury to occur. Furthermore, hypoxia-ischemia severe enough to produce irreversible tissue injury is always associated with major perturbations in the energy status of the perinatal brain which persists well into the recovery period. The lingering energy depletion sets in motion a cascade of biochemical alterations that are initiated during the course of the insult and proceed well into the recovery period to culminate in either neuronal necrosis or infarction. Unlike the adult, where glucose supplementation prior to or during hypoxia-ischemia accentuates tissue injury, glucose treatment of perinatal animals subjected to a similar insult substantially reduces the extent of tissue injury. The mechanism for the age-specific effect of glucose on hypoxic-ischemic brain damage is discussed in relation to pathogenetic mechanisms responsible for the occurrence of permanent brain damage.

Entities:  

Mesh:

Year:  1992        PMID: 1343838     DOI: 10.1111/j.1750-3639.1992.tb00696.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  9 in total

1.  Contribution of the blood glucose level in perinatal asphyxia.

Authors:  Pallab Basu; Sabbasachi Som; Nabendu Choudhuri; Harendranath Das
Journal:  Eur J Pediatr       Date:  2008-10-09       Impact factor: 3.183

2.  Hypothermia for hypoxic-ischemic encephalopathy.

Authors:  C Michael Cotten; Seetha Shankaran
Journal:  Expert Rev Obstet Gynecol       Date:  2010-03-01

3.  In utero hypoxic ischemia decreases the cholinergic agonist-stimulated poly-phosphoinositide turnover in the developing rat brain.

Authors:  K Hersey; Z Y Hu; J P Zhang; P G Rhodes; G Y Sun
Journal:  Neurochem Res       Date:  1995-12       Impact factor: 3.996

4.  Understanding neonatal hypoxic-ischemic encephalopathy with metabolomics.

Authors:  N Efstathiou; G Theodoridis; K Sarafidis
Journal:  Hippokratia       Date:  2017 Jul-Sep       Impact factor: 0.471

5.  The effects of perinatal hypoxia on the behavioral, neurochemical, and neurohistological toxicity of the metabolic inhibitor 3-nitropropionic acid.

Authors:  Z Binienda; D L Frederick; S A Ferguson; R L Rountree; M G Paule; L Schmued; S F Ali; W Slikker; A C Scallet
Journal:  Metab Brain Dis       Date:  1995-12       Impact factor: 3.584

6.  Repeated fluorodeoxyglucose positron emission tomography of the brain in infants with suspected hypoxic-ischaemic brain injury.

Authors:  H Suhonen-Polvi; P Kero; H Korvenranta; U Ruotsalainen; M Haaparanta; J Bergman; O Simell; U Wegelius
Journal:  Eur J Nucl Med       Date:  1993-09

Review 7.  Glucocorticoids and preterm hypoxic-ischemic brain injury: the good and the bad.

Authors:  Laura Bennet; Joanne O Davidson; Miriam Koome; Alistair Jan Gunn
Journal:  J Pregnancy       Date:  2012-08-16

Review 8.  Neuroprotective Effects of Diabetes Drugs for the Treatment of Neonatal Hypoxia-Ischemia Encephalopathy.

Authors:  Laura Poupon-Bejuit; Eridan Rocha-Ferreira; Claire Thornton; Henrik Hagberg; Ahad A Rahim
Journal:  Front Cell Neurosci       Date:  2020-05-06       Impact factor: 5.505

9.  1H nuclear magnetic resonance brain metabolomics in neonatal mice after hypoxia-ischemia distinguished normothermic recovery from mild hypothermia recoveries.

Authors:  Jia Liu; R Ann Sheldon; Mark R Segal; Mark J S Kelly; Jeffrey G Pelton; Donna M Ferriero; Thomas L James; Lawrence Litt
Journal:  Pediatr Res       Date:  2013-05-24       Impact factor: 3.756

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.